BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7298289)

  • 1. A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis.
    Pak CY
    Invest Urol; 1981 Nov; 19(3):187-90. PubMed ID: 7298289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium cellulose phosphate-induced increment in urinary calcium/magnesium ratio.
    Revusova V; Gratzlova J; Zvara V; Kridl J; Landsmanova L
    Eur Urol; 1975; 1(6):294-6. PubMed ID: 1233199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resorptive and absorptive hypercalciuria. Therapy with sodium cellulose phosphate or thiazides.
    Hering F; Lutzeyer W
    Eur Urol; 1979; 5(1):29-31. PubMed ID: 428408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and management of hypercalciuric nephrolithiasis.
    Breslau NA
    Miner Electrolyte Metab; 1994; 20(6):328-39. PubMed ID: 7783695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium oxalate stone disease: effects and side effects of cellulose phosphate and succinate in long-term treatment of absorptive hypercalciuria or hyperoxaluria.
    Hautmann R; Hering FJ; Lutzeyer W
    J Urol; 1978 Dec; 120(6):712-5. PubMed ID: 731812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate.
    Pak CY; Delea CS; Bartter FC
    N Engl J Med; 1974 Jan; 290(4):175-80. PubMed ID: 4808916
    [No Abstract]   [Full Text] [Related]  

  • 10. Absorptive hyperoxaluria: a new clinical entity--successful treatment with hydrochlorothiazide.
    Yendt ER; Cohanim M
    Clin Invest Med; 1986; 9(1):44-50. PubMed ID: 3955921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look].
    Hess B
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2460-70. PubMed ID: 8571096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and chemical factors in kidney calculus formation in childhood. An analysis of 40 patients].
    Böhles H; Brandl U; Schott G; Stehr K
    Monatsschr Kinderheilkd; 1984 Mar; 132(3):158-62. PubMed ID: 6727888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the question of endocrine side effects in patients on medication for renal calcium stone disease (author's transl)].
    Ziegler R; Uhl K; Minne H; Russmann D; Döring B
    Urologe A; 1980 Jul; 19(4):226-30. PubMed ID: 7414768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal tubular function in children with hypercalciuria].
    Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
    Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of hypercalciuria with thiazides, sodium or potassium cellulose phosphate, separately or in combination.
    Lutzeyer W; Hering F; Hautmann R
    Trans Am Assoc Genitourin Surg; 1979; 71():67-9. PubMed ID: 545817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of calcium calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):325-33. PubMed ID: 3576853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis.
    Cohanim M; Yendt ER
    Invest Urol; 1980 Sep; 18(2):170-3. PubMed ID: 7410033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.